B. Arnieri

An evaluation of the impact of missing deaths on overall survival analyses of advanced non–small cell lung cancer patients conducted in an electronic health records database

S. Griffith, Aracelis Z. Torres, Michael D. Taylor, 2019, Pharmacoepidemiology and drug safety.

Validation of diagnosis codes to identify side of colon in an electronic health record registry

P. Luhn, N. Meropol, D. Kuk, 2017, BMC Medical Research Methodology.

Evaluating eligibility criteria of oncology trials using real-world data and AI

Ruishan Liu, James Zou, S. Rizzo, 2021, Nature.

Changing Demographics and Treatment Patterns in Patients the United States with Chronic Lymphocytic Leukemia in the First-Line Setting As Assessed Using a Novel Electronic Health Record Database

C. Bernaards, K. Humphrey, C. Hirst, 2016 .

Development and Validation of a High‐Quality Composite Real‐World Mortality Endpoint

A. Abernethy, S. Griffith, Michael D. Taylor, 2018, Health services research.

Using Electronic Health Records to Derive Control Arms for Early Phase Single‐Arm Lung Cancer Trials: Proof‐of‐Concept in Randomized Controlled Trials

William B. Capra, Ryan Copping, K. Rothman, 2019, Clinical pharmacology and therapeutics.

382 Phase Ib study of oral dual-PI3K/mTOR inhibitor GDC-0980 in combination with capecitabine and mFOLFOX6 + bevacizumab in patients with advanced solid tumors and colorectal cancer

J. Ware, J. Spoerke, S. Leong, 2014 .